Ypsomed to distribute Insulet's OmniPod device in 11 countries

01/5/2010 | American City Business Journals

Insulet has signed a five-year agreement that will see Swiss firm Ypsomed Distribution exclusively market its OmniPod Insulin Management System in 11 countries. The deal could be worth more than $100 million. Ypsomed will start distributing the product in Western Europe and Australia during the next six months and introduce it in China by early next year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA